From CNN Brasil · Helena Barra · · 50s
TL;DR: Experimental Vaccine Extends Life in Severe Leukemia Cases
Experimental leukemia vaccine boosts survival by over nine months for severe blood cancer patients.
A new experimental vaccine for acute myeloid leukemia significantly increases median survival from 14.7 to 24 months in patients who completed chemotherapy. Experimental leukemia vaccine boosts survival by over nine months for severe blood cancer patients. The vaccine trains the patient's immune system to recognize and destroy residual cancer cells after chemotherapy.
- Experimental Vaccine Boosts Survival
- How the Vaccine Works
- Key Results of Study
- Next Steps for Approval
Read the story version — the same reporting as a swipeable deck of 4 cards.






